{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:43:50Z","timestamp":1787021030328,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Transformation of low-grade follicular lymphoma to high-grade diffuse large B cell lymphoma (DLBCL) is known. However, the opposite is not commonly reported. In this report, we present a case of follicular lymphoma that underwent transformation to DLBCL. Three years after treatment for histologic transformation, the patient presented again with low-grade follicular lymphoma at the same site which is unusual in the natural history of follicular lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 50-year-old female patient presented to us with complaints of slowly progressing swelling in the neck on the left side for a duration of 1 year. Past history of the patient revealed a diagnosis of follicular lymphoma in 2004 for which the patient had taken prednisolone and chlorambucil. Details of staging were not available with the patient. After a complete work-up, she was diagnosed as DLBCL, stage IIIE. She was treated with 6\u2009cycles of CHOP regimen. She had very good response to chemotherapy. However, she defaulted and was lost to follow-up. She presented again after 3 years with history of painless progressive swelling in the right side of the neck for the last 1 year. Examination revealed cervical lymph nodes and ascites. This time, a repeat biopsy and immunohistochemistry was suggestive of follicular lymphoma. In view of significant ascites, she was started on chemotherapy with CVP regimen. After 6\u2009cycles, she has good partial response and resolution of ascites. She is currently on follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have presented a case of FL that has transformed to DLBCL after 10\u2009years of diagnosis. After HT, she was treated with CHOP chemotherapy and the patient relapsed again after 3 years with follicular lymphoma histology. This case highlights the unique and varied natural history of follicular lymphoma that may be attributed to different subclones of malignant cells that may have arisen from a common progenitor FL cell and differential effect of chemotherapy on these subclones.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-020-00035-3","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:10:14Z","timestamp":1589447414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse\u2014a case report"],"prefix":"10.1186","volume":"32","author":[{"given":"M. C.","family":"Suresh Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-4561","authenticated-orcid":false,"given":"Antony George Francis","family":"Thottian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lokanatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linu Abraham","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. N.","family":"Lokesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Rudresha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. K.","family":"Rajeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saldanha","family":"Smitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Adil","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khandare Pravin","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Premalatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Suma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"issue":"9","key":"35_CR1","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bjc.2015.94","volume":"112","author":"A Smith","year":"2015","unstructured":"Smith A, et al. Lymphoma incidence, survival and prevalence 2004\u20132014: sub-type analyses from the UK\u2019s Haematological Malignancy Research Network. Br J Cancer. 2015;112(9):1575\u201384. https:\/\/doi.org\/10.1038\/bjc.2015.94.","journal-title":"Br J Cancer"},{"issue":"6","key":"35_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443\u201359. https:\/\/doi.org\/10.3322\/caac.21357.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"35_CR3","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","volume":"116","author":"M Sant","year":"2010","unstructured":"Sant M, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724\u201334. https:\/\/doi.org\/10.1182\/blood-2010-05-282632.","journal-title":"Blood"},{"issue":"1","key":"35_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265\u201376. https:\/\/doi.org\/10.1182\/blood-2005-06-2508.","journal-title":"Blood"},{"issue":"32","key":"35_CR5","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","volume":"26","author":"AJ Al-Tourah","year":"2008","unstructured":"Al-Tourah AJ, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(32):5165\u20139. https:\/\/doi.org\/10.1200\/JCO.2008.16.0283.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"35_CR6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","volume":"15","author":"Y Bastion","year":"1997","unstructured":"Bastion Y, et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(4):1587\u201394. https:\/\/doi.org\/10.1200\/JCO.1997.15.4.1587.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"17","key":"35_CR7","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","volume":"25","author":"S Montoto","year":"2007","unstructured":"Montoto S, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(17):2426\u201333. https:\/\/doi.org\/10.1200\/JCO.2006.09.3260.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"35_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275\u201382. https:\/\/doi.org\/10.1182\/blood-2003-05-1545.","journal-title":"Blood"},{"issue":"11","key":"35_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol Off J Am Soc Clin Oncol. 1989;7(11):1630\u20136. https:\/\/doi.org\/10.1200\/JCO.1989.7.11.1630.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"35_CR10","doi-asserted-by":"publisher","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project, \u201cA predictive model for aggressive non-Hodgkin\u2019s lymphoma,\u201d N. Engl. J. Med., vol. 329, no. 14, pp. 987\u2013994, 30 1993, doi: https:\/\/doi.org\/10.1056\/NEJM199309303291402.","DOI":"10.1056\/NEJM199309303291402"},{"issue":"19","key":"35_CR11","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019\u201332. https:\/\/doi.org\/10.1182\/blood-2011-01-293050.","journal-title":"Blood"},{"issue":"23","key":"35_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","volume":"311","author":"SJ Horning","year":"1984","unstructured":"Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas. N Engl J Med. 1984;311(23):1471\u20135. https:\/\/doi.org\/10.1056\/NEJM198412063112303.","journal-title":"N Engl J Med"},{"issue":"23","key":"35_CR13","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","volume":"33","author":"C Casulo","year":"2015","unstructured":"Casulo C, et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(23):2516\u201322. https:\/\/doi.org\/10.1200\/JCO.2014.59.7534.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"35_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","volume":"126","author":"ND Wagner-Johnston","year":"2015","unstructured":"Wagner-Johnston ND, et al. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood. 2015;126(7):851\u20137. https:\/\/doi.org\/10.1182\/blood-2015-01-621375.","journal-title":"Blood"},{"issue":"33","key":"35_CR15","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","volume":"24","author":"H Ghesqui\u00e8res","year":"2006","unstructured":"Ghesqui\u00e8res H, et al. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(33):5234\u201341. https:\/\/doi.org\/10.1200\/JCO.2006.07.5671.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"35_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1182\/blood.V96.2.635","volume":"96","author":"IS Lossos","year":"2000","unstructured":"Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5\u2019 noncoding regulatory region of the BCL-6 gene. Blood. 2000;96(2):635\u20139.","journal-title":"Blood"},{"issue":"9","key":"35_CR17","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/sj.leu.2402578","volume":"16","author":"IS Lossos","year":"2002","unstructured":"Lossos IS, Warnke R, Levy R. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5\u2019 regulatory region of the BCL-6 gene. Leukemia. 2002;16(9):1857\u201362. https:\/\/doi.org\/10.1038\/sj.leu.2402578.","journal-title":"Leukemia"},{"issue":"4","key":"35_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","volume":"102","author":"T Akasaka","year":"2003","unstructured":"Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood. 2003;102(4):1443\u20138. https:\/\/doi.org\/10.1182\/blood-2002-08-2482.","journal-title":"Blood"},{"issue":"18","key":"35_CR19","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","volume":"126","author":"R Kridel","year":"2015","unstructured":"Kridel R, et al. Cell of origin of transformed follicular lymphoma. Blood. 2015;126(18):2118\u201327. https:\/\/doi.org\/10.1182\/blood-2015-06-649905.","journal-title":"Blood"},{"issue":"2","key":"35_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","volume":"24","author":"IS Lossos","year":"2011","unstructured":"Lossos IS, Gascoyne RD. Transformation of follicular lymphoma. Best Pract Res Clin Haematol. 2011;24(2):147\u201363. https:\/\/doi.org\/10.1016\/j.beha.2011.02.006.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"35_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","volume":"20","author":"A Noy","year":"2009","unstructured":"Noy A, et al. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol. Mar. 2009;20(3):508\u201312. https:\/\/doi.org\/10.1093\/annonc\/mdn657.","journal-title":"Ann Oncol"},{"issue":"1","key":"35_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","volume":"125","author":"C Casulo","year":"2015","unstructured":"Casulo C, Burack WR, Friedberg JW. Transformed follicular non-Hodgkin lymphoma. Blood. 2015;125(1):40\u20137. https:\/\/doi.org\/10.1182\/blood-2014-04-516815.","journal-title":"Blood"},{"issue":"1","key":"35_CR23","first-page":"324","volume":"11","author":"P Xu","year":"2018","unstructured":"Xu P, et al. Development of follicular lymphoma after treatment of diffuse large B-cell lymphoma: two case reports with review of literature. Int J Clin Exp Pathol. 2018;11(1):324\u201332.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-020-00035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-020-00035-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-020-00035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:09:49Z","timestamp":1620932989000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-020-00035-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1186\/s43046-020-00035-3","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent from patient to publish was taken.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}